Ghost Tree Capital, LLC Hedge Fund

CIK: 0001595851 · Show all filings

Period: Q3 2019 (← Previous) (Next →)

Filing Date: Apr 9, 2020

Total Value: $393M (100.0% shares, 0.0% debt)

Holdings (44)

XBI SPDR SERIES TRUST 7.8%
Value $30.58M Shares 401,000 Share Price $76.25 Est. Cost/Share — Unrealized @ Report Date —
SPY SPDR S&P 500 ETF TR 7.6%
Value $29.68M Shares 100,000 Share Price $296.77 Est. Cost/Share — Unrealized @ Report Date —
— BLUEPRINT MEDICINES CORP 6.1%
Value $23.88M Shares 325,000 Share Price $73.47 Est. Cost/Share $85.19 Unrealized @ Report Date —
— MIRATI THERAPEUTICS INC 5.5%
Value $21.43M Shares 275,000 Share Price $77.91 Est. Cost/Share $71.66 Unrealized @ Report Date —
SRPT SAREPTA THERAPEUTICS INC 4.2%
Value $16.57M Shares 220,000 Share Price $75.32 * Est. Cost/Share $121.54 Unrealized @ Report Date -2.8%
— IMMUNOMEDICS INC 4.1%
Value $15.93M Shares 1,201,000 Share Price $13.26 Est. Cost/Share $9.20 Unrealized @ Report Date —
— SAGE THERAPEUTICS INC 3.9%
Value $15.43M Shares 110,000 Share Price $140.29 Est. Cost/Share $145.19 Unrealized @ Report Date —
SRPT SAREPTA THERAPEUTICS INC 3.8%
Value $15.06M Shares 200,000 Share Price $75.32 * Est. Cost/Share $121.54 Unrealized @ Report Date -2.8%
— BIOHAVEN PHARMACTL HLDG CO L 3.7%
Value $14.6M Shares 350,000 Share Price $41.72 Est. Cost/Share $42.31 Unrealized @ Report Date —
ASND ASCENDIS PHARMA A S 3.7%
Value $14.45M Shares 150,000 Share Price $96.32 Est. Cost/Share $95.44 Unrealized @ Report Date —
QQQ INVESCO QQQ TR 3.6%
Value $14.16M Shares 75,000 Share Price $188.81 Est. Cost/Share — Unrealized @ Report Date —
FOLD AMICUS THERAPEUTICS INC 3.5%
Value $13.67M Shares 1,705,000 Share Price $8.02 * Est. Cost/Share $11.59 Unrealized @ Report Date -6.3%
AXSM AXSOME THERAPEUTICS INC 3.5%
Value $13.66M Shares 675,000 Share Price $20.24 * Est. Cost/Share $16.12 Unrealized @ Report Date +59.4%
FXB INVESCO CURNCYSHS BRIT PND S 3.2%
Value $12.59M Shares 105,600 Share Price $119.25 Est. Cost/Share $119.25 Unrealized @ Report Date —
BMRN BIOMARIN PHARMACEUTICAL INC 3.2%
Value $12.47M Shares 185,000 Share Price $67.40 * Est. Cost/Share $77.02 Unrealized @ Report Date 0.0%
— IMMUNOMEDICS INC 2.4%
Value $9.614M Shares 725,000 Share Price $13.26 Est. Cost/Share $9.20 Unrealized @ Report Date —
PCRX PACIRA PHARMACEUTICALS INC 2.4%
Value $9.518M Shares 250,000 Share Price $38.07 * Est. Cost/Share $39.91 Unrealized @ Report Date 0.0%
IOVA IOVANCE BIOTHERAPEUTICS INC 2.3%
Value $9.1M Shares 500,000 Share Price $18.20 * Est. Cost/Share $18.38 Unrealized @ Report Date +20.3%
— ADVERUM BIOTECHNOLOGIES INC 2.0%
Value $7.903M Shares 1,450,000 Share Price $5.45 Est. Cost/Share $5.45 Unrealized @ Report Date —
RCKT ROCKET PHARMACEUTICALS INC 1.9%
Value $7.281M Shares 625,000 Share Price $11.65 * Est. Cost/Share $15.68 Unrealized @ Report Date -20.9%
— ATHENEX INC 1.6%
Value $6.356M Shares 522,500 Share Price $12.16 Est. Cost/Share $12.16 Unrealized @ Report Date —
ARGX ARGENX SE 1.5%
Value $5.698M Shares 50,000 Share Price $113.96 Est. Cost/Share $141.58 Unrealized @ Report Date —
FATE FATE THERAPEUTICS INC 1.4%
Value $5.436M Shares 350,000 Share Price $15.53 * Est. Cost/Share $19.17 Unrealized @ Report Date 0.0%
— TURNING POINT THERAPEUTICS I 1.2%
Value $4.7M Shares 125,000 Share Price $37.60 Est. Cost/Share $37.60 Unrealized @ Report Date —
— MOMENTA PHARMACEUTICALS INC 1.2%
Value $4.536M Shares 350,000 Share Price $12.96 Est. Cost/Share $12.26 Unrealized @ Report Date —
— KADMON HLDGS INC 1.1%
Value $4.41M Shares 1,750,000 Share Price $2.52 Est. Cost/Share $3.79 Unrealized @ Report Date —
FXF INVESCO CURNCYSHS SWISS FRAN 1.1%
Value $4.399M Shares 47,500 Share Price $92.61 Est. Cost/Share $94.55 Unrealized @ Report Date —
MIST MILESTONE PHARMACEUTICALS IN 1.1%
Value $4.383M Shares 235,000 Share Price $18.65 * Est. Cost/Share $20.62 Unrealized @ Report Date -4.4%
— AERIE PHARMACEUTICALS INC 1.1%
Value $4.325M Shares 225,000 Share Price $19.22 Est. Cost/Share $19.22 Unrealized @ Report Date —
BCRX BIOCRYST PHARMACEUTICALS 1.1%
Value $4.298M Shares 1,500,000 Share Price $2.87 * Est. Cost/Share $6.16 Unrealized @ Report Date -49.5%
— HOMOLOGY MEDICINES INC 1.0%
Value $4.073M Shares 225,000 Share Price $18.10 Est. Cost/Share $18.92 Unrealized @ Report Date —
— REATA PHARMACEUTICALS INC 1.0%
Value $4.015M Shares 50,000 Share Price $80.30 Est. Cost/Share $80.30 Unrealized @ Report Date —
ARVN ARVINAS INC 1.0%
Value $3.987M Shares 185,000 Share Price $21.55 * Est. Cost/Share $17.47 Unrealized @ Report Date +40.4%
KALV KALVISTA PHARMACEUTICALS INC 0.9%
Value $3.654M Shares 315,000 Share Price $11.60 * Est. Cost/Share $16.59 Unrealized @ Report Date -2.6%
— DICERNA PHARMACEUTICALS INC 0.9%
Value $3.375M Shares 235,000 Share Price $14.36 Est. Cost/Share $15.75 Unrealized @ Report Date —
PTGX PROTAGONIST THERAPEUTICS INC 0.8%
Value $3.003M Shares 250,000 Share Price $12.01 * Est. Cost/Share $9.58 Unrealized @ Report Date +31.5%
— ORCHARD THERAPEUTICS PLC 0.7%
Value $2.886M Shares 242,950 Share Price $11.88 Est. Cost/Share $15.73 Unrealized @ Report Date —
VRAYQ VIEWRAY INC 0.6%
Value $2.393M Shares 825,000 Share Price $2.90 * Est. Cost/Share $6.89 Unrealized @ Report Date -14.0%
— CYMABAY THERAPEUTICS INC 0.6%
Value $2.253M Shares 440,000 Share Price $5.12 Est. Cost/Share $11.75 Unrealized @ Report Date —
— AVROBIO INC 0.6%
Value $2.192M Shares 155,253 Share Price $14.12 Est. Cost/Share $14.12 Unrealized @ Report Date —
— CHIASMA INC 0.5%
Value $1.893M Shares 382,500 Share Price $4.95 Est. Cost/Share $5.20 Unrealized @ Report Date —
— EPIZYME INC 0.3%
Value $1.362M Shares 132,000 Share Price $10.32 Est. Cost/Share $12.39 Unrealized @ Report Date —
— SOLID BIOSCIENCES INC 0.3%
Value $1.034M Shares 100,000 Share Price $10.34 Est. Cost/Share $9.20 Unrealized @ Report Date —
— DERMIRA INC 0.1%
Value $272K Shares 42,500 Share Price $6.40 Est. Cost/Share $6.40 Unrealized @ Report Date —